Back to Market Feed

Historical record - last NADAC effective date: 7/1/2024

Product Information

TIROSINT 62.5 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.5494 per EA under NDC 71858001704. Its NADAC has been published 25 times since Apr 17, 2024.

FDA first approved this application on Oct 13, 2006.

The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIROSINT 62.5 MCG CAPSULE

levothyroxine sodium
$4.5494per EA
High Outlier

Strength

62.5 ug/1

Manufacturer

IBSA Pharma Inc.

NDC

71858001704

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

7/1/2024

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021924

FDA Approved

10/13/2006

On Market Since

3/1/2023

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for TIROSINT 62.5 MCG CAPSULE has been published 25 times since Apr 17, 2024, and over the history we have for it it has risen 3.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.5494 per EA
All-time high$4.5494 (Oct 2, 2024)
All-time low$4.3883 (Apr 17, 2024)
Median price$4.5494
Average price$4.4852
Largest weekly change+3.7% (Jun 26, 2024)
Weeks tracked25
Tracking sinceApr 17, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+3.7%

Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levothyroxine sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

THYQUIDITY 100 MCG/5 ML SOLN
Brand
82685036002•Oliva Therapeutics, LLC
$1.3844
per ML
SYNTHROID 300 MCG TABLET
Brand
00074714919•AbbVie Inc.
$1.6563
per EA
SYNTHROID 300 MCG TABLET
Brand
00074714990•AbbVie Inc.
$1.6563
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714811•AbbVie Inc.
$1.6577
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714819•AbbVie Inc.
$1.6577
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714890•AbbVie Inc.
$1.6577
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707019•AbbVie Inc.
$1.6592
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707090•AbbVie Inc.
$1.6592
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434119•AbbVie Inc.
$1.6593
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434190•AbbVie Inc.
$1.6593
per EA

Frequently asked questions

What is the NADAC price of TIROSINT 62.5 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 62.5 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.5494 per EA (NDC 71858001704), effective Oct 2, 2024.

How has the price of TIROSINT 62.5 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIROSINT 62.5 MCG CAPSULE has risen 3.7%. It has been tracked across 25 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for TIROSINT 62.5 MCG CAPSULE?

Since Apr 17, 2024, the NADAC for TIROSINT 62.5 MCG CAPSULE has ranged from a low of $4.3883 (Apr 17, 2024) to a high of $4.5494 (Oct 2, 2024), with a median of $4.5494 per EA.

Are there cheaper alternatives to TIROSINT 62.5 MCG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of TIROSINT 62.5 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TIROSINT 62.5 MCG CAPSULE?

TIROSINT 62.5 MCG CAPSULE (NDC 71858001704) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.